AMRX
NASDAQ · Pharmaceuticals
Amneal Pharmaceuticals Inc
$19.45
-0.50 (-2.51%)
Performance
1D
—
1W
-9.58%
1M
-1.02%
3M
+8.78%
6M
+52.19%
1Y
+66.81%
YTD
+53.63%
Open$20.04
Previous Close$19.95
Day High$20.48
Day Low$19.39
52W High$21.68
52W Low$9.99
Volume—
Avg Volume4.25M
Market Cap6.87B
P/E Ratio43.65
EPS$0.48
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$19.26
Above
SMA 200
$15.85
Above
RSI (14)
57.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
13 analysts
Price Target
+494.0% upside
Current
$19.45
$19.45
Target
$115.54
$115.54
$65.43
$115.54 avg
$156.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.33B | 3.00B | 607.96M |
| Net Income | 79.44M | 64.46M | 209.30M |
| Profit Margin | 2.4% | 2.3% | 34.4% |
| EBITDA | 681.09M | 583.34M | 317.16M |
| Free Cash Flow | — | — | 187.04M |
| Rev Growth | +10.9% | +10.9% | -4.4% |
| Debt/Equity | 136.58 | 136.58 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |